La nostra Storia

LE ORIGINI
1990-1991 L’IDEA DELLA CARBOSSITERAPIA
1992-1993 COSA VUOL DIRE “CARBOSSITERAPIA”
1994-1995 UNA RICERCA HIGH-IMPACT
1996: LA NASCITA DI CARBOMED
1996: IL LAVORO IN UNIVERSITÀ
1998-2001 RICONOSCIMENTI INTERNAZIONALI
2004-2005 IL GRUPPO DI RICERCA
2006-2008 FOCUS SULLE INNOVAZIONI
2009-2010 AVVICINARSI AL MEDICO
2013-2014 UN NUOVO INIZIO
2015-2016 NUOVE LINEE DI BUSINESS
2017 PUNTARE ALL’ECCELLENZA
2019 L’IMPORTANZA DELL’INNOVAZIONE
OGGI – UN PATRIMONIO UNICO PER LA MEDICINA

From a personal problem to an unexpected solution

Raynaud syndrome is a rare illness of affecting blood vessels causing the diminishing of blood flow in hands and feet. affected by this pathology, in 1990, Roberto Parmigiani goes to Royat, in France, where CO2 bath were already known as an effective treatment for vascular patholigies.

terme di Royat

Our history: his intellectual curiosity pushes Roberto to imagine that CO2 may be more effective if submitted through intradermal injection. His experience in biology and his personal experience proving efficacy in thermal use, turn into the desire to test on himself this intuition. However, how to do it? </span

morbo di raynaud

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.

Origins

From a personal problem to an unexpected solution

1990-1991 THE IDEA OF CARBOXYTHERAPY

The first steps in research

Thanks to the acquaintance of Dr. Lattarulo, who was working at the Micro-Angiology Centre of the Monza Polyclinic during the 90s, Roberto meets professor Curri, director of the centre, whose precious collaboration allow the studies on the effects of CO2 injections on human microcirculation system.

First micro-angeologic evaluations were made with the use of Laser Doppler Flow, instrument which monitors the increase, or decrease, of blood flow and oxigen concentration in tissues (Curri, Lattarulo, Albergati).

1992-1993 What does it mean “CARBOXYTHERAPY”

Same word,
a new methodic

The first years of clinical observation see the spreading of the word “Carboxytherapy” meant as controlled submission of medical CO2 through intradermal injection. before, it was meant only as thermal treatment.

It comes the time to give a body to our work: Carbossiterapia Italiana Srl is born. This society is thought to develop this new methodic and discover all medical applications. As trademark, an atom is chosen to underline the scientific approach of the work in progress.

1994-1995 HIGH-IMPACT RESEARCH

Initial difficulties in the consolidation of the methodic

Given the first evidences of its efficacy, it is vital to scientifically demonstrate how it works, as Galileo has taught us all. How to obtain results with a relevant scientific base? It is necessary to develop a medical device able to measure in a precise way all data in order to control them quantitatively.

That’s why we invest all our energies in the development of a medical device.

The first prototype was simply provided with a mechanic flowmeter measuring the speed of gas while coming out of the device. It was a mere gas dispenser, but it was not enough. How to measure the gas flow that is actually intradermally injected.

1996: LA NASCITA DI CARBOMED

The achievement of a special “sensibility”

Efforts during previous years brings to the creation of a software that electronically measures, through sensors, the resistance meet by the gas in the tissue.

The control of resistance, which is subject to continue and constant variations in relation to the type and condition of the treated area, is fundamental for therapy efficacy.

Without this control, it would not be possible of being sure of gas quantity injected in tissues and treatment result would be different from patient to patient. Thanks to this system it is possible to obtain treatment results replicable whenever and however it is wished.

I valori vengono gestiti da un software che controlla un sistema elettrovalvole permettendo di aumentare o diminuire automaticamente il flusso in uscita dal device per bilanciare la variazione di resistenza. In questo modo il medico può impostare e monitorare esattamente il flusso di CO2 che viene realmente iniettato nel tessuto. Questo sistema di controllo elettronico del flusso tramite software viene brevettato internazionalmente, proprio perché la sua precisione garantisce il controllo da parte del medico e quindi l’efficacia del trattamento, nonché la sua riproducibilità. Il device viene così certificato UNI ISO, UNI CEI e IQNET.

1996: UNIVERSITY RESEARCH

The birth of the scientific group in Italy

The device is ready for clinical research and we start coordinating and financing the firsts scientific studies on Carboxytherapy with the support of Professor Carlo D’Aniello, head of Plastic Surgery Department of the University of Siena.

At the same time, we build the first Italian Group for Studies on Carboxytherapy (GISC) to share clinical experiences. Since that moment, we develop a sales department in Italy and we become the first supplier of Carboxytherapy device worldwide.

1998-2001 INTERNATIONAL ACKNOWLEDGEMENTS

One step forward: the first scientific results

Thanks to the implementation of the European Directive for Medical Devices (Directive 93/42/CEE), Carbomed obtains the CE certification n° 0051 for medical devices of IIB class, certified as the only device within the whole European Community authorized to inject CO2 in an invasive manner. IIB class identifies a device that can perform a direct invasive activity.

Negli stessi anni vengono pubblicati i primi articoli scientifici impattati su riviste come Aesthetic Plastic Surgery e viene istituito il primo Corso Universitario di Carbossiterapia presso la cattedra di chirurgia plastica dell’Università degli studi di Siena diretta dal Professor Carlo D’Aniello.

2004-2005 THE RESEARCH GROUP

GISC becomes international

Given the clinical experiences obtained worldwide, continuously accredited by official publications, it becomes a duty to expand the scientific group at the international level: from Italian Group for Studies on Carboxytherapy to International Group for Studies on Carboxytherapy, maintaining the GISC abbreviation.

È arrivato il momento di tracciare delle linee guida per la Carbossiterapia intesa come metodica invasiva, nei vari ambiti di applicazione conosciuti. Per questo nel 2005 organizziamo il Primo Meeting internazionale del GISC riunendo specialisti provenienti da Europa, Asia, America Latina e Stati Uniti per un confronto basato sulle esperienze personali nell’uso della Carbossiterapia con i nostri device: vengono tracciate le prime linee guida della metodica per l’applicazione in chirurgia plastica, medicina estetica, dermatologia e flebologia.

2006-2008 FOCUS ON INNOVATIONS

When theory and practice meet: Carbomed CDT Evolution

The knowledge acquired thanks to international experiences gives us the incentive to improve our technical innovation: we develop and patent a better solution, an evolution of the previous device that we call Carbomed CDT Evolution (Carbon Dioxide Therapy Evolution), simply known as CDT Evolution.

This new device is always based on the patent on electronic control of gas flow. In addition, it can control temperature, sterility and humidity of CO2 during its erogation. Moreover, thanks to the GISC studies, we update the software and create standardized programs for aesthetic medicine, anti-aging treatments, ulcers and difficult wounds.

2009-2010 GETTING CLOSER TO DOCTORS

Carboxytherapy prêt-à-porter: Carbomed CDT Light

When Carboxytherapy begins to be daily used, we satisfy doctors’ needs: lanciamo CDT Light, versione portatile di CDT Evolution, per ovviare alle necessità di trasporto e di spazio nelle cliniche studiamo dei nuovi protocolli di trattamento con un focus sulle “tecniche integrate”, per quei medici che volevano sperimentare la Carbossiterapia in combinazione con altre metodiche.

2013-2014 A NEW BEGINNING

New opportunities looking at Asia: the ShapingUp line

Thanks to the extraordinary collaboration with Carboxy Asia (Joy Medicom), our partner since 2002, Carbossiterapia Italiana create a new products line that react to the need of “resolve but do not distort”: a reassuring slogan inviting to practice aesthetic medicine without exaggerate.

With this core idea, we realize the ShapingUp line, a new type of absorbable PDO threads (sutures made in polydioxanone of class 4) that - thanks to their elasticity and resistance - stimulate the natural production of skin collagen, making possible to perform soft-lifting without surgery.

RESOLVE BUT DO NOT DISTORT

2015-2016 NEW BUSINESS LINES

Broadening our market:
Raffine and Celtick

Given the very positive result obtained with ShapingUp, Carbossiterapia Italiana enters the market of new products: we become exclusive distributors in Europe of Raffine, a microneedling device, and of Celtick, an electronic microinjector. Thought to be used together with Carboxytherapy treatments, they mark the first step towards completentary methodic.

2017 AIMING AT EXCELLENCE

Succeed in the known and specialize in a new field: Élevance PDO

Our experience with the PDO threads line ShapingUp let us identify a new market need: an absorbable PDO long lasting and more resistant. A thread with which it is possible to do a real non-surgical lifting. After years of research, we launch a new generation of PDO lifting threads with excellent strength and life: Élevance.

In the same year, we update carboxytherapy protocols of treatment and the methodic guidelines on the basis of new studies on different fields of applications; namely, trichology, gynecology, andrology, and pain therapy.

2019 l’importanza dell’Innovazione

CDT LIGHT HIGH TECH: 30 anni di ricerca condensati nel device per la Carbossiterapia definitivo

Assecondando le esigenze dei nostri clienti, introduciamo un device per Carbossiterapia sempre più adatto a un utilizzo ambulatoriale.
Evolviamo quindi alla CDT Light High Tech, versione trasportabile e con schermo touch, studiato per un inserimento real time dei parametri.
Con questo device apportiamo significative migliorie al software e implementiamo i protocolli di trattamento.

TODAY: A UNIQUE HERITAGE FOR MEDICINE

Old passions and new territories

Everyday, we engage in the defense, development and promotion of the methodic called “CARBOXYTHERAPY”, a unique heritage for medicine. We are responsible for spreading and teaching our heredity of competences and knowledge that we had the chance to collect during years and that always need to be fed.

To reach this goal we are focusing on:

Ricerca scientifica, per sviluppare la metodica in nuovi ambiti di applicazione;
Formazione teorica e pratica della classe medica
sensibilizzazione riguardo a:
- Utilizzo di strumenti adatti a questa terapia, sicuri ed affidabili;
- Reali indicazioni e controindicazioni a livello terapeutico;
- Corrette tecniche di esecuzione